Due to these findings, oral Wegovy would currently be my preferred choice when cardiovascular risk reduction is top priority, says Anton, noting that both medications seem promising for people focused primarily on blood glucose control or creating modest improvements in blood pressure and cholesterol
Trials funded by Novo Nordisk have shown a mean weight loss of up to 15% from oral semaglutide in adults without diabetes
Available from: Sandra Christensen 1 , Katie Robinson 2 , Sara Thomas 2 , Dominique R Williams 2 Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: A narrative review and discussion of research needs
( B ) Schematic of drug delivery and IRI protocol of Langendorff perfusion using isolated hearts from 10- to 12-week-old C57BL6J WT mice ( C ) LVDP recovery expressed as a percentage of LVDP at the end of reperfusion over LVDP before ischemia
This warning is based on rodent studies where the drugs caused changes in thyroid cells
Provider Review A medical provider will look over your answers and determine if youre a good fit
